Literature DB >> 17719258

Listeria as a vaccine vector.

Kevin W Bruhn1, Noah Craft, Jeff F Miller.   

Abstract

The immunostimulatory characteristics and intracellular niche of Listeria monocytogenes make it uniquely suitable for use as a live bacterial vaccine vector. Preclinical results supporting this idea, and current strategies to induce beneficial cell-mediated immunity to both infectious diseases and cancer with this vector, are discussed in this review.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17719258     DOI： 10.1016/j.micinf.2007.05.010

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  26 in total

1.  The intact structural form of LLO in endosomes cannot protect against listeriosis.

Authors:  Estela Rodriguez-Del Rio; Elisabet Frande-Cabanes; Raquel Tobes; Eduardo Pareja; M Jesús Lecea-Cuello; Marta Ruiz-Sáez; Eugenio Carrasco-Marín; Carmen Alvarez-Dominguez
Journal:  Int J Biochem Mol Biol       Date:  2011-07-15

2.  Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active prfA* Regulon Boosts Mycobacterium bovis BCG Efficacy against Tuberculosis.

Authors:  Qingmei Jia; Barbara Jane Dillon; Saša Masleša-Galić; Marcus A Horwitz
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

3.  A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.

Authors:  Qingmei Jia; Richard Bowen; Jacob Sahakian; Barbara Jane Dillon; Marcus A Horwitz
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

4.  Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.

Authors:  Xiaolu Xiong; Jun Jiao; Anthony E Gregory; Pengcheng Wang; Yujing Bi; Xiaoyi Wang; Yongqiang Jiang; Bohai Wen; Daniel A Portnoy; James E Samuel; Chen Chen
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

5.  Sensing of Bacterial Cyclic Dinucleotides by the Oxidoreductase RECON Promotes NF-κB Activation and Shapes a Proinflammatory Antibacterial State.

Authors:  Adelle P McFarland; Shukun Luo; Fariha Ahmed-Qadri; Meghan Zuck; Elizabeth F Thayer; Young Ah Goo; Kevin Hybiske; Liang Tong; Joshua J Woodward
Journal:  Immunity       Date:  2017-03-21       Impact factor: 31.745

6.  An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.

Authors:  Matthew M Seavey; Paulo C Maciag; Nada Al-Rawi; Duane Sewell; Yvonne Paterson
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 7.  Rationally designed tularemia vaccines.

Authors:  Barbara J Mann; Nicole M Ark
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217

8.  Selected prfA* mutations in recombinant attenuated Listeria monocytogenes strains augment expression of foreign immunogens and enhance vaccine-elicited humoral and cellular immune responses.

Authors:  Lin Yan; Jin Qiu; Jianbo Chen; Bridgett Ryan-Payseur; Dan Huang; Yunqi Wang; Lijun Rong; Jody A Melton-Witt; Nancy E Freitag; Zheng W Chen
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

Review 9.  Listeria monocytogenes - from saprophyte to intracellular pathogen.

Authors:  Nancy E Freitag; Gary C Port; Maurine D Miner
Journal:  Nat Rev Microbiol       Date:  2009-08-03       Impact factor: 60.633

10.  Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains.

Authors:  Peter Lauer; Bill Hanson; Edward E Lemmens; Weiqun Liu; William S Luckett; Meredith L Leong; Heather E Allen; Justin Skoble; Keith S Bahjat; Nancy E Freitag; Dirk G Brockstedt; Thomas W Dubensky
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.